Literature DB >> 9810883

Cutaneous small-vessel vasculitis.

T Lotti1, I Ghersetich, C Comacchi, J L Jorizzo.   

Abstract

Cutaneous small-vessel vasculitis (CSVV) refers to a group of disorders usually characterized by palpable purpura; it is caused by leukocytoclastic vasculitis of postcapillary venules. CSVV can be idiopathic or can be associated with a drug, infection, or underlying systemic disease. Initially, the pathogenesis of CSVV is immune complex related, but in its later stages different pathogenetic mechanisms may intensify the reaction and lymphocytes may predominate in the infiltrate. Cure requires elimination of the cause (ie, drugs, chemicals, infections, food allergens) when possible, as well as therapy with nonsteroidal antiinflammatory agents, corticosteroids, dapsone, potassium iodide, fibrinolytic agents, aminocaproic acid, immunosuppressive agents (ie, cyclophosphamide, azathioprine, methotrexate, cyclosporine) or even monoclonal antibodies, depending on disease severity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9810883     DOI: 10.1016/s0190-9622(98)70039-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  15 in total

1.  [Leukocytoclastic vasculitis].

Authors:  C Sunderkötter; J Roth; G Bonsmann
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

2.  Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall.

Authors:  Caroline Maris Takatu; Antonio Pedro Ribeiro Heringer; Valéria Aoki; Neusa Yuriko Sakai Valente; Paula Cristina de Faria Sanchez; Jozélio Freire de Carvalho; Paulo Ricardo Criado
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 3.  Ceftriaxone-induced leukocytoclastic vasculitis: a case report and literature review of antibiotic-induced leukocytoclastic vasculitis.

Authors:  Aseel A Almasoudi; Eman S Bablghaith; Samaher I Alaauldeen; Ayman M Falemban; Ahlam A Sherbeeni; Adeeb A Bulkhi
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

4.  Blocking von Willebrand factor for treatment of cutaneous inflammation.

Authors:  Carina Hillgruber; Annika K Steingräber; Birgit Pöppelmann; Cécile V Denis; Jerry Ware; Dietmar Vestweber; Bernhard Nieswandt; Stefan W Schneider; Tobias Goerge
Journal:  J Invest Dermatol       Date:  2013-06-28       Impact factor: 8.551

5.  Primary Cutaneous Small Vessel Vasculitis.

Authors:  James P. Russell; Roger H. Weenig
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-04

6.  Leucocytoclastic vasculitis: A complication after streptokinase therapy for acute myocardial infarction.

Authors:  Manisha Makkar; Neha Garg; Nek Chand Mahajan
Journal:  Niger Med J       Date:  2013-07

7.  Cutaneous small vessel vasculitis accompanied by pustulosis palmaris et plantaris.

Authors:  Motoko Kosaka; Tokue Kato; Seiji Kawana
Journal:  Case Rep Dermatol       Date:  2012-03-23

8.  Leukocytoclastic vasculitis in a patient with ankylosing spondylitis.

Authors:  Senol Kobak; Hatice Yilmaz; Ahmet Karaarslan; Murat Yalcin
Journal:  Case Rep Rheumatol       Date:  2014-02-05

9.  A Phase II Multicenter Trial With Rivaroxaban in the Treatment of Livedoid Vasculopathy Assessing Pain on a Visual Analog Scale.

Authors:  Attyla Drabik; Carina Hillgruber; Tobias Goerge
Journal:  JMIR Res Protoc       Date:  2014-12-10

10.  The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features.

Authors:  Javier Loricera; Vanesa Calvo-Río; Francisco Ortiz-Sanjuán; Marcos A González-López; Hector Fernández-Llaca; Javier Rueda-Gotor; Maria C Gonzalez-Vela; Lino Alvarez; Cristina Mata; Domingo González-Lamuño; Victor M Martínez-Taboada; Miguel A González-Gay; Ricardo Blanco
Journal:  Medicine (Baltimore)       Date:  2013-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.